<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01787110</url>
  </required_header>
  <id_info>
    <org_study_id>DETO2X-AMI 2012/287-12</org_study_id>
    <nct_id>NCT01787110</nct_id>
  </id_info>
  <brief_title>An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction</brief_title>
  <acronym>DETO2X-AMI</acronym>
  <official_title>DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Heart Lung Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swedish Foundation for Strategic Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI)
      is manifested in international treatment guidelines and established in prehospital and
      hospital clinical routine throughout the world.

      However, to date there is no conclusive evidence from adequately designed and powered trials
      supporting this practice. Existing data is conflicting and failing to clarify the role of
      supplemental oxygen in AMI.

      The DETO2X-AMI trial is designed to shed light on this important issue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AIM:

      The aim of the DETO2X-AMI trial is to evaluate the role of supplemental oxygen delivery in
      the setting of acute coronary syndrome myocardial infarction including ST-segment elevation
      myocardial infarction (STEMI), non ST-segment elevation myocardial infarction (NSTEMI) and
      unstable angina (UA).

      DESIGN:

      DETO2X-AMI is a multicentre, interventional, controlled, randomized registry based clinical
      trial (RRCT) recruiting 6600 patients at cardiac care facilities which report into the
      SWEDEHEART registry throughout the whole of Sweden.

      The SWEDEHEART (Swedish Web-system for Enhancement and Development of Evidence-based care in
      Heart disease Evaluated According to Recommended Therapies) registry is a nationwide used
      platform allowing a broad population of all-comers access to the broad registry network which
      includes:

        -  RIKS-HIA (nationwide registry where all ischemia cases treated on cardiac intensive care
           units are registered),

        -  SCAAR (Swedish Coronary Angiography and Angioplasty Registry where nationwide all
           coronary angiography and percutaneous coronary intervention (PCI) procedures are
           registered))

        -  SEPHIA (nationwide registry for all post AMI follow-up in patients below 75 years of
           age).

      All follow-up will be carried out in SWEDEHEART and other national registries such as the
      national cause of death register (dödsorsaksregister) or the national patient register
      (slutenvårdsregister). A similar set-up has been successfully used for the TASTE (Thrombus
      Aspiration in ST-Elevation myocardial infarction in Scandinavia) trial.

      MATERIAL and METHODS:

      Patients with normal oxygen saturation (≥90% on pulse oximeter) presenting to the ambulance
      service or the emergency department (ED) with classical symptoms suggestive of acute coronary
      syndrome (ACS) and significant ECG changes or elevated cardiac biomarkers (ED) are evaluated
      for inclusion. If eligible, oral informed consent is obtained by EMD or ED personnel prior to
      inclusion. Randomization is carried out on the cardiac intensive care unit using a web-based
      tool as part of registration directly into the national SWEDEHEART registry.

      Patients are randomized to either supplemental oxygen delivered by oxymask® (6 L/min) for 12
      hours (min 6 hours) or no supplemental O₂. All patients receive standard care according to
      international ACS guidelines including acute coronary intervention.

      EFFICACY OUTCOMES:

      Primary efficacy outcome

      All-cause mortality at one year in all patients with suspected AMI (ITT).

      Secondary efficacy outcomes

      In the ITT population and AMI cohort:

        -  MACE 1: composite of all-cause mortality or rehospitalization with heart failure*

        -  MACE 2: composite of all-cause mortality or rehospitalization with heart failure or
           readmission with myocardial infarction

        -  rehospitalization with heart failure

        -  rehospitalization with AMI

        -  rehospitalization with shock (Kilip ≥3)*

        -  cardiovascular death *

        -  health economy

      In the STEMI cohort: MACE as a composite of all-cause death, rehospitalization with MI,
      cardiogenic shock, or stent thrombosis* plus as above.

      *These outcomes were specified after the trial had started, but before any treatment
      comparisons were available.

      Primary and secondary outcomes will be assessed at 30 days and one year of follow up.
      Supplementary per-protocol analysis will be performed.

      Subgroup analyses consist of predefined subgroups including gender, age, AMI/Non-AMI, Type-I
      AMI ( STEMI/NSTEMI), smokers, Hb, oxygen saturation levels, patients with chronic obstructive
      pulmonary disease, chronic kidney disease and diabetes mellitus.

      Two main sub studies will be performed:

      DETO2X-Biomarkers, a multicenter sub study to the DETO2X-AMI trial assessing if oxygen
      treatment enhances oxidative stress, systemic inflammation, and markers of apoptosis and MMPs
      in ACS patients, thereby potentially increasing myocardial damage and cell death, and
      potentially the prognosis (see separate trial protocol or clinicaltrials.gov NCT02290080 for
      details).

      DETO2X-OXYPAIN 2, a multicenter sub study to the DETO2X-AMI trial at centers with catheter
      laboratories evaluating a possible analgesic effect of oxygen in using visual-analog scale
      (VAS).

      Follow-up is carried out according to clinical post AMI routine which includes a standardized
      registration in the SWEDEHEART registry. Mortality data is obtained from the national cause
      of death register which is linked to SWEDEHEART.

      CONCLUSION:

      There is no conclusive evidence from adequately designed and powered trials supporting the
      routine administration of supplemental oxygen in the setting of suspected AMI. The DETO2X-AMI
      trial is designed to shed light on this important issue and give guidance to future
      recommendations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">December 30, 2016</completion_date>
  <primary_completion_date type="Actual">December 30, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1-year all-cause mortality</measure>
    <time_frame>1 year</time_frame>
    <description>1-year all-cause mortality on an intention to treat basis (ITT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE 1</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause mortality or rehospitalization with heart failure at 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE 2</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause mortality or rehospitalization with heart failure or readmission with myocardial infarction at 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STEMI-PCI-MACE</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause death or rehospitalization with MI or cardiogenic shock or stent thrombosis at one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization with heart failure</measure>
    <time_frame>1 year</time_frame>
    <description>Rehospitalization with heart failure at 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization with AMI</measure>
    <time_frame>1 year</time_frame>
    <description>Rehospitalization with AMI at 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization with shock (Killip ≥3)</measure>
    <time_frame>1 year</time_frame>
    <description>Rehospitalization with shock (Killip ≥3) at 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular death</measure>
    <time_frame>1 year</time_frame>
    <description>Cardiovascular death at 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economics</measure>
    <time_frame>1 year</time_frame>
    <description>Health economics concerning supplemental oxygen treatment from prehospital contact of the emergency service, hospital stay until follow-up 1 year in patients with AMI below 75 years of age</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6629</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Non-ST Elevation (NSTEMI) Myocardial Infarction</condition>
  <condition>Acute ST Segment Elevation Myocardial Infarction</condition>
  <condition>Angina, Unstable</condition>
  <arm_group>
    <arm_group_label>No oxygen</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>For patients randomised to withholding oxygen treatment
no oxygen is administered at any time as long as the oxygen saturation is ≥90% on pulse oximeter (repetitive checks are performed)
all patients receive standard acute coronary syndrome treatment including reperfusion strategies
observation duration 12 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For patients randomised to oxygen therapy:
6 L/min of oxygen delivered by oxymask® started immediately after inclusion of the ambulance service or in the emergency department given continuously for 6-12 hours (at least 6 hours)
all patients receive standard acute coronary syndrome treatment including reperfusion strategies</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>see arm description</description>
    <arm_group_label>Oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptoms (chest pain, dyspnea) indicating acute myocardial ischemia within the last 6
             hours

          -  ECG changes (ST-segment elevation ≥ 2 mm V1-V4, or ≥ 1 mm in other leads, ST-segment
             depression &gt;1 mm in any lead, negative T-wave in leads V2-V6, pathological Q-wave in
             at least 2 adjacent leads), left bundle branch block

        and/or elevated levels of cardiac troponin levels in the ED

        indicating acute myocardial ischemia

          -  oxygen saturation ≥90% (pulse oximeter)

          -  age ≥30

        Exclusion Criteria:

          -  unwillingness to participate

          -  inability to comprehend given information

          -  continuous oxygen delivery at home prior to inclusion

          -  cardiac arrest prior to inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leif Svensson, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Enköping Hospital</name>
      <address>
        <city>Enköping</city>
        <zip>74525</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gothenburg University Hospital, Sahlgrenska</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gothenburg University Hospital, Östra</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gävle Hospital</name>
      <address>
        <city>Gävle</city>
        <zip>80187</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hallands Hospital Halmstad</name>
      <address>
        <city>Halmstad</city>
        <zip>30185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ryhov Hospital Jönköping</name>
      <address>
        <city>Jönköping</city>
        <zip>55185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalmar Regional Hospital</name>
      <address>
        <city>Kalmar</city>
        <zip>39185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karlstad Hospital</name>
      <address>
        <city>Karlstad</city>
        <zip>65185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kiruna Hospital</name>
      <address>
        <city>Kiruna</city>
        <zip>98131</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kristianstad Hospital</name>
      <address>
        <city>Kristianstad</city>
        <zip>29185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Köping Hospital</name>
      <address>
        <city>Köping</city>
        <zip>73130</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skaraborgs Hospital Lidköping</name>
      <address>
        <city>Lidköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>58191</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skåne University Hospital Lund</name>
      <address>
        <city>Lund</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skåne University Hospital Malmö</name>
      <address>
        <city>Malmö</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Universitetssjukhus Mölndal</name>
      <address>
        <city>Mölndal</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vrinnevi Hospital Norrköping</name>
      <address>
        <city>Norrköping</city>
        <zip>60329</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norrtälje Hospital</name>
      <address>
        <city>Norrtälje</city>
        <zip>76129</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nyköping Hospital</name>
      <address>
        <city>Nyköping</city>
        <zip>61185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skaraborgs Hospital Skövde</name>
      <address>
        <city>Skövde</city>
        <zip>54185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St: Göran Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>11281</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>11883</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital Huddinge</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital Solna</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Danderyds Sjukhus</name>
      <address>
        <city>Stockholm</city>
        <zip>18288</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Härnosand Hospital Sundsvall</name>
      <address>
        <city>Sundsvall</city>
        <zip>85186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trelleborg Hospital</name>
      <address>
        <city>Trelleborg</city>
        <zip>23185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norrlands University Hospital</name>
      <address>
        <city>Umeå</city>
        <zip>90185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hallands Hospital Varberg</name>
      <address>
        <city>Varberg</city>
        <zip>43281</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Växjö Hospital</name>
      <address>
        <city>Växjö</city>
        <zip>35188</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Örnsköldsvik Hospital</name>
      <address>
        <city>Örnsköldsvik</city>
        <zip>89189</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Östersund Hospital</name>
      <address>
        <city>Östersund</city>
        <zip>83183</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://www.deto2x.se</url>
    <description>Click here for more information about this study</description>
  </link>
  <reference>
    <citation>Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J. 1976 May 8;1(6018):1121-3.</citation>
    <PMID>773507</PMID>
  </reference>
  <reference>
    <citation>Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Beasley R. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J. 2009 Sep;158(3):371-7. doi: 10.1016/j.ahj.2009.05.037. Epub 2009 Jul 15. Review.</citation>
    <PMID>19699859</PMID>
  </reference>
  <reference>
    <citation>Ranchord AM, Argyle R, Beynon R, Perrin K, Sharma V, Weatherall M, Simmonds M, Heatlie G, Brooks N, Beasley R. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. Am Heart J. 2012 Feb;163(2):168-75. doi: 10.1016/j.ahj.2011.10.013. Epub 2012 Jan 13.</citation>
    <PMID>22305833</PMID>
  </reference>
  <reference>
    <citation>Ukholkina GB, Kostianov IIu, Kuchkina NV, Grendo EP, Gofman IaB. [Effect of oxygenotherapy used in combination with reperfusion in patients with acute myocardial infarction]. Kardiologiia. 2005;45(5):59. Russian.</citation>
    <PMID>16007057</PMID>
  </reference>
  <reference>
    <citation>Moradkhan R, Sinoway LI. Revisiting the role of oxygen therapy in cardiac patients. J Am Coll Cardiol. 2010 Sep 21;56(13):1013-6. doi: 10.1016/j.jacc.2010.04.052.</citation>
    <PMID>20846598</PMID>
  </reference>
  <reference>
    <citation>Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007160. doi: 10.1002/14651858.CD007160.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD007160.</citation>
    <PMID>20556775</PMID>
  </reference>
  <reference>
    <citation>Burls A, Cabello JB, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute myocardial infarction: a systematic review and meta-analysis. Emerg Med J. 2011 Nov;28(11):917-23. doi: 10.1136/emj.2010.103564. Epub 2011 Feb 23. Review.</citation>
    <PMID>21346260</PMID>
  </reference>
  <reference>
    <citation>Fröbert O, Lagerqvist B, Gudnason T, Thuesen L, Svensson R, Olivecrona GK, James SK. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010 Dec;160(6):1042-8. doi: 10.1016/j.ahj.2010.08.040.</citation>
    <PMID>21146656</PMID>
  </reference>
  <reference>
    <citation>Kones R. Oxygen therapy for acute myocardial infarction-then and now. A century of uncertainty. Am J Med. 2011 Nov;124(11):1000-5. doi: 10.1016/j.amjmed.2011.04.034. Review.</citation>
    <PMID>22017777</PMID>
  </reference>
  <reference>
    <citation>Shuvy M, Atar D, Gabriel Steg P, Halvorsen S, Jolly S, Yusuf S, Lotan C. Oxygen therapy in acute coronary syndrome: are the benefits worth the risk? Eur Heart J. 2013 Jun;34(22):1630-5. doi: 10.1093/eurheartj/eht110. Epub 2013 Apr 3. Review.</citation>
    <PMID>23554440</PMID>
  </reference>
  <reference>
    <citation>Stub D, Smith K, Bernard S, Bray JE, Stephenson M, Cameron P, Meredith I, Kaye DM; AVOID Study. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study). Am Heart J. 2012 Mar;163(3):339-345.e1. doi: 10.1016/j.ahj.2011.11.011.</citation>
    <PMID>22424003</PMID>
  </reference>
  <reference>
    <citation>Hofmann R, James SK, Svensson L, Witt N, Frick M, Lindahl B, Östlund O, Ekelund U, Erlinge D, Herlitz J, Jernberg T. DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. Am Heart J. 2014 Mar;167(3):322-8. doi: 10.1016/j.ahj.2013.09.022. Epub 2013 Dec 19.</citation>
    <PMID>24576515</PMID>
  </reference>
  <reference>
    <citation>Fröbert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, Aasa M, Angerås O, Calais F, Danielewicz M, Erlinge D, Hellsten L, Jensen U, Johansson AC, Kåregren A, Nilsson J, Robertson L, Sandhall L, Sjögren I, Ostlund O, Harnek J, James SK; TASTE Trial. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013 Oct 24;369(17):1587-97. doi: 10.1056/NEJMoa1308789. Epub 2013 Aug 31. Erratum in: N Engl J Med. 2014 Aug 21;371(8):786.</citation>
    <PMID>23991656</PMID>
  </reference>
  <reference>
    <citation>Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM; AVOID Investigators. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation. 2015 Jun 16;131(24):2143-50. doi: 10.1161/CIRCULATIONAHA.114.014494. Epub 2015 May 22.</citation>
    <PMID>26002889</PMID>
  </reference>
  <reference>
    <citation>Bulluck H, Hausenloy DJ. Letter by Bulluck and Hausenloy Regarding Article, &quot;Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction&quot;. Circulation. 2016 Jan 19;133(3):e28. doi: 10.1161/CIRCULATIONAHA.115.017968.</citation>
    <PMID>26783282</PMID>
  </reference>
  <reference>
    <citation>Nehme Z, Stub D, Bernard S, Stephenson M, Bray JE, Cameron P, Meredith IT, Barger B, Ellims AH, Taylor AJ, Kaye DM, Smith K; AVOID Investigators. Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction. Heart. 2016 Mar;102(6):444-51. doi: 10.1136/heartjnl-2015-308636. Epub 2016 Jan 6.</citation>
    <PMID>26740484</PMID>
  </reference>
  <reference>
    <citation>James S, Rao SV, Granger CB. Registry-based randomized clinical trials--a new clinical trial paradigm. Nat Rev Cardiol. 2015 May;12(5):312-6. doi: 10.1038/nrcardio.2015.33. Epub 2015 Mar 17. Review.</citation>
    <PMID>25781411</PMID>
  </reference>
  <reference>
    <citation>Nedeljkovic ZS, Jacobs AK. Oxygen for ST-Segment-Elevation Myocardial Infarction: Still Up in the Air. Circulation. 2015 Jun 16;131(24):2101-3. doi: 10.1161/CIRCULATIONAHA.115.017072. Epub 2015 May 22.</citation>
    <PMID>26002888</PMID>
  </reference>
  <reference>
    <citation>Sepehrvand N, Ezekowitz JA. Oxygen Therapy in Patients With Acute Heart Failure: Friend or Foe? JACC Heart Fail. 2016 Oct;4(10):783-790. doi: 10.1016/j.jchf.2016.03.026. Epub 2016 Jun 8. Review.</citation>
    <PMID>27289409</PMID>
  </reference>
  <reference>
    <citation>Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM. Response to Letter Regarding Article, &quot;Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction&quot;. Circulation. 2016 Jan 19;133(3):e29. doi: 10.1161/CIRCULATIONAHA.115.019038.</citation>
    <PMID>26783283</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2013</study_first_submitted>
  <study_first_submitted_qc>February 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2013</study_first_posted>
  <last_update_submitted>December 8, 2017</last_update_submitted>
  <last_update_submitted_qc>December 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Leif Svensson</investigator_full_name>
    <investigator_title>Professor of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Acute coronary syndrome</keyword>
  <keyword>Acute myocardial infarction</keyword>
  <keyword>Non ST-segment Myocardial Infarction</keyword>
  <keyword>ST-segment Myocardial Infarction</keyword>
  <keyword>STEMI</keyword>
  <keyword>NSTEMI</keyword>
  <keyword>Oxygen</keyword>
  <keyword>Unstable angina</keyword>
  <keyword>Randomised trial</keyword>
  <keyword>CMR</keyword>
  <keyword>Mortality</keyword>
  <keyword>RCRT</keyword>
  <keyword>RRCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

